Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» February 2012
February 2012
Santarus, Depomed settle dispute with Lupin
Santarus, Depomed settle dispute with Lupin
Reuters
Depomed
Lupin
Santarus
Glumetza
diabetes
generics
Theravance: A $1.5 Billion Company With An $8 Billion Product
Theravance: A $1.5 Billion Company With An $8 Billion Product
Seeking Alpha
Theravance
GSK
Pfizer
Relovair
Advair
AstraZeneca
asthma
COPD
Prevnar trial results needed for CDC recommendation
Prevnar trial results needed for CDC recommendation
Reuters
Prevnar 13
vaccines
CDC
pneumonia
Novartis' Rasilez to Carry Warning Novartis' Rasilez to Carry Warning
Novartis' Rasilez to Carry Warning Novartis' Rasilez to Carry Warning
Yahoo/AP
Mylan
guidance
Teva Pays $250M To Settle Propofol Lawsuits
Teva Pays $250M To Settle Propofol Lawsuits
Pharmalot
Teva Pharmaceuticals
settlements
propofol
anesthesia
Endo Pharmaceuticals Earnings Preview
Endo Pharmaceuticals Earnings Preview
Motley Fool
earnings
Endo
J.&J. Offers Concessions to Win Approval for Synthes Deal
J.&J. Offers Concessions to Win Approval for Synthes Deal
NY Times, NY
JNJ
Synthes
M&A
Should doc-payment rules require more info?
Should doc-payment rules require more info?
Fierce Pharma
Physician Payment Sunshine Act
physician payments
Pfizer reportedly weighing animal health IPO
Pfizer reportedly weighing animal health IPO
Fierce Pharma
IPO
Pfizer
animal health
The Cure for Alexion
The Cure for Alexion
TheStreet.com
Alexion
PNH
Soliris
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »